CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Concert Pharm - CNCE CFD

    8.34
    0%
    0.09
    Market Trading Hours* (UTC) Opens on Monday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.09
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.024874%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.002651%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* N/A
    Open* N/A
    1-Year Change* N/A
    Day's Range* N/A
    52 wk Range 2.66-8.55
    Average Volume (10 days) 2.59M
    Average Volume (3 months) 43.80M
    Market Cap 401.24M
    P/E Ratio -100.00K
    Shares Outstanding 47.94M
    Revenue 42.00K
    EPS -2.93
    Dividend (Yield %) N/A
    Beta 0.53
    Next Earnings Date May 3, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Mar 27, 2023 8.34 0.00 0.00% 8.34 8.34 8.34
    Mar 14, 2023 8.34 0.00 0.00% 8.34 8.34 8.34
    Mar 3, 2023 8.34 0.01 0.12% 8.33 8.50 8.31
    Mar 2, 2023 8.33 -0.01 -0.12% 8.34 8.34 8.30
    Mar 1, 2023 8.34 0.01 0.12% 8.33 8.34 8.33
    Feb 28, 2023 8.34 -0.01 -0.12% 8.35 8.35 8.34
    Feb 27, 2023 8.34 0.00 0.00% 8.34 8.36 8.34
    Feb 24, 2023 8.34 -0.01 -0.12% 8.35 8.35 8.33
    Feb 23, 2023 8.35 0.00 0.00% 8.35 8.36 8.35
    Feb 22, 2023 8.34 0.02 0.24% 8.32 8.36 8.32
    Feb 21, 2023 8.31 -0.03 -0.36% 8.34 8.36 8.30
    Feb 17, 2023 8.34 0.00 0.00% 8.34 8.37 8.33
    Feb 16, 2023 8.34 0.03 0.36% 8.31 8.36 8.30
    Feb 15, 2023 8.31 -0.01 -0.12% 8.32 8.33 8.29
    Feb 14, 2023 8.29 0.00 0.00% 8.29 8.31 8.28
    Feb 13, 2023 8.28 -0.02 -0.24% 8.30 8.31 8.28
    Feb 10, 2023 8.29 0.00 0.00% 8.29 8.30 8.28
    Feb 9, 2023 8.28 -0.06 -0.72% 8.34 8.35 8.27
    Feb 8, 2023 8.31 -0.02 -0.24% 8.33 8.33 8.30
    Feb 7, 2023 8.31 -0.03 -0.36% 8.34 8.36 8.31

    Concert Pharm Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total revenue 32.578 7.902 1.077 10.505 143.891
    Revenue 32.578 7.902 1.077 10.505 143.891
    Total Operating Expense 110.086 80.549 80.092 66.089 52.674
    Selling/General/Admin. Expenses, Total 22.248 18.624 19.97 22.94 21.019
    Research & Development 87.555 61.624 59.816 43.149 30.223
    Operating Income -77.508 -72.647 -79.015 -55.584 91.217
    Interest Income (Expense), Net Non-Operating -2.543 -2.204 0.837 -0.139 0.521
    Net Income Before Taxes -80.051 -74.851 -78.166 -55.711 95.339
    Net Income After Taxes -80.051 -74.766 -78.166 -56.024 95.639
    Net Income Before Extra. Items -80.051 -74.766 -78.166 -56.024 95.639
    Net Income -80.051 -74.766 -78.166 -56.024 95.639
    Total Adjustments to Net Income 0 -0.444
    Income Available to Common Excl. Extra. Items -80.051 -74.766 -78.166 -56.024 95.195
    Income Available to Common Incl. Extra. Items -80.051 -74.766 -78.166 -56.024 95.195
    Diluted Net Income -80.051 -74.766 -78.166 -56.024 95.21
    Diluted Weighted Average Shares 34.405 31.2 23.74 23.37 23.442
    Diluted EPS Excluding Extraordinary Items -2.32673 -2.39635 -3.29259 -2.39726 4.06151
    Dividends per Share - Common Stock Primary Issue
    Diluted Normalized EPS -2.32673 -2.39635 -3.29259 -2.39726 4.10122
    Unusual Expense (Income) 0 1.432
    Other, Net 0 0 0.012 0.012 3.601
    Total Extraordinary Items 0
    Dilution Adjustment 0.015
    Depreciation / Amortization 0.283 0.301 0.306
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total revenue 0 0.013 0.543 32.017 0.005
    Revenue 0 0.013 0.543 32.017 0.005
    Total Operating Expense 36.028 32.965 27.338 25.798 23.985
    Selling/General/Admin. Expenses, Total 5.467 5.909 5.393 5.537 5.409
    Research & Development 30.489 26.995 21.876 20.184 18.5
    Depreciation / Amortization 0.072 0.061 0.069 0.077 0.076
    Operating Income -36.028 -32.952 -26.795 6.219 -23.98
    Interest Income (Expense), Net Non-Operating -1.7 -3.177 0.117 -0.794 1.311
    Net Income Before Taxes -37.728 -36.129 -26.678 5.425 -22.669
    Net Income After Taxes -37.728 -36.129 -26.678 5.425 -22.669
    Net Income Before Extra. Items -37.728 -36.129 -26.678 5.425 -22.669
    Net Income -37.728 -36.129 -26.678 5.425 -22.669
    Total Adjustments to Net Income -0.01 0.01
    Income Available to Common Excl. Extra. Items -37.728 -36.129 -26.678 5.415 -22.659
    Income Available to Common Incl. Extra. Items -37.728 -36.129 -26.678 5.415 -22.659
    Diluted Net Income -37.728 -36.129 -26.678 5.415 -22.659
    Diluted Weighted Average Shares 36.687 35.659 34.09 34.083 33.954
    Diluted EPS Excluding Extraordinary Items -1.02838 -1.01318 -0.78258 0.15888 -0.66734
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -1.02838 -1.01318 -0.78258 0.15888 -0.66734
    Other, Net 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 150.329 142.724 116.855 180.149 205.734
    Cash and Short Term Investments 143.099 131.937 111.813 160.839 203.165
    Cash 8.786 7.274 10.261 8.379 19.557
    Cash & Equivalents 132.85 69.928 42.782 9.391 8.108
    Short Term Investments 1.463 54.735 58.77 143.069 175.5
    Total Receivables, Net 0.218 3.177 0.332 16.571 0.783
    Accounts Receivable - Trade, Net 0.218 0.686 0.072 16.015 0.155
    Prepaid Expenses 6.997 7.61 4.567 2.739 1.786
    Total Assets 165.316 159.263 137.471 192.547 211.736
    Property/Plant/Equipment, Total - Net 13.827 15.331 17.005 8.919 2.165
    Property/Plant/Equipment, Total - Gross 17.937 19.331 19.93 10.431 9.532
    Accumulated Depreciation, Total -4.11 -4 -2.925 -1.512 -7.367
    Other Long Term Assets, Total 1.16 1.208 1.253 1.157 1.591
    Total Current Liabilities 16.12 10.178 17.268 8.749 6.445
    Accounts Payable 2.606 0.23 0.881 1.277 0.658
    Accrued Expenses 5.866 5.33 4.352 3.739 3.425
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 7.648 4.618 12.035 3.733 2.362
    Total Liabilities 53.091 28.101 36.014 24.807 15.304
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 36.971 17.923 18.746 16.058 8.859
    Total Equity 112.225 131.162 101.457 167.74 196.432
    Common Stock 0.034 0.031 0.024 0.023 0.023
    Additional Paid-In Capital 461.765 400.636 296.145 284.369 273.059
    Retained Earnings (Accumulated Deficit) -349.498 -269.447 -194.681 -116.515 -76.243
    Other Equity, Total -0.076 -0.058 -0.031
    Total Liabilities & Shareholders’ Equity 165.316 159.263 137.471 192.547 211.736
    Total Common Shares Outstanding 34.739 31.8622 23.8651 23.4376 23.1404
    Note Receivable - Long Term 0 2.358 2.322 2.246
    Unrealized Gain (Loss) -0.137 -0.407
    Redeemable Preferred Stock 0 0
    Other Current Assets, Total 0.015 0 0.143
    Preferred Stock - Non Redeemable, Net 0
    Total Preferred Shares Outstanding 0.014
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 114.768 150.329 112.908 132.983 123.855
    Cash and Short Term Investments 109.905 143.099 106.223 124.845 115.036
    Cash 14.423 8.786 7.817 3.554 7.964
    Cash & Equivalents 44.94 132.85 95.847 118.845 81.808
    Short Term Investments 50.542 1.463 2.559 2.446 25.264
    Total Receivables, Net 0.995 0.218 0.476 0.241 2.452
    Accounts Receivable - Trade, Net 0.744 0.218 0.476 0.24 0.079
    Prepaid Expenses 3.868 6.997 6.167 7.882 6.367
    Total Assets 129.411 165.316 128.208 148.705 139.991
    Property/Plant/Equipment, Total - Net 13.484 13.827 14.133 14.544 14.947
    Other Long Term Assets, Total 1.159 1.16 1.167 1.178 1.189
    Total Current Liabilities 15.082 16.12 12.021 8.67 8.303
    Accounts Payable 2.755 2.606 0.584 0 0.508
    Accrued Expenses 2.707 5.866 4.101 3.435 2.528
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 9.62 7.648 7.336 5.235 5.267
    Total Liabilities 52.845 53.091 29.046 25.989 25.952
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 37.763 36.971 17.025 17.319 17.649
    Total Equity 76.566 112.225 99.162 122.716 114.039
    Preferred Stock - Non Redeemable, Net 0 0 0
    Common Stock 0.034 0.034 0.031 0.031 0.031
    Additional Paid-In Capital 463.876 461.765 412.576 409.452 406.198
    Retained Earnings (Accumulated Deficit) -387.226 -349.498 -313.369 -286.691 -292.116
    Other Equity, Total -0.118 -0.076 -0.076 -0.076 -0.074
    Total Liabilities & Shareholders’ Equity 129.411 165.316 128.208 148.705 139.991
    Total Common Shares Outstanding 34.9533 34.739 32.4068 32.1738 32.1738
    Other Current Assets, Total 0 0.015 0.042 0.015
    Total Preferred Shares Outstanding 0.014 0.014
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line -80.051 -74.766 -78.166 -56.024 95.639
    Cash From Operating Activities -55.154 -69.037 -48.761 -48.029 104.084
    Cash From Operating Activities 1.479 1.605 1.664 1.247 1.008
    Non-Cash Items 15.585 14.849 11.693 2.778 9.91
    Cash Taxes Paid 0 0.459 0.123 1.9
    Cash Interest Paid 0 0.648
    Changes in Working Capital 7.833 -10.725 16.048 3.97 -2.473
    Cash From Investing Activities 52.458 0.344 82.583 37.903 -121.307
    Capital Expenditures -0.255 -0.21 -0.685 -2.869 -0.947
    Other Investing Cash Flow Items, Total 52.713 0.554 83.268 40.772 -120.36
    Cash From Financing Activities 67.13 92.852 1.451 -0.169 5.49
    Financing Cash Flow Items 2.575 21.955
    Issuance (Retirement) of Stock, Net 64.555 70.897 1.451 -0.169 6.576
    Issuance (Retirement) of Debt, Net 0 -1.086
    Net Change in Cash 64.434 24.159 35.273 -10.295 -11.733
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -37.728 -80.051 -43.922 -17.244 -22.669
    Cash From Operating Activities -32.324 -55.154 -28.676 -10.04 -20.714
    Cash From Operating Activities 0.321 1.479 1.153 0.785 0.392
    Non-Cash Items 4.119 15.585 9.535 6.419 2.258
    Changes in Working Capital 0.964 7.833 4.558 0 -0.695
    Cash From Investing Activities -49.949 52.458 52.474 52.573 30.62
    Capital Expenditures -0.092 -0.255 -0.239 -0.14 -0.092
    Other Investing Cash Flow Items, Total -49.857 52.713 52.713 52.713 30.712
    Cash From Financing Activities 0 67.13 2.664 2.664 2.664
    Financing Cash Flow Items 0 2.575 0 0 2.575
    Issuance (Retirement) of Stock, Net 0 64.555 2.664 2.664 0.089
    Net Change in Cash -82.273 64.434 26.462 45.197 12.57

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    500K+

    Trader

    92K+

    Klien aktif per bulan

    $53M+

    Volume investasi per bulan

    $30M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Biotechnology & Medical Research (NEC)

    Suite 3000N
    65 Hayden Avenue
    LEXINGTON
    MASSACHUSETTS 02421
    US

    Income Statement

    • Annual
    • Quarterly

    People also watch

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    Biaya inap posisi Long -0.0156%
    Biaya inap posisi short -0.0063%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    BTC/USD

    28,570.05 Price
    +1.300% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    Biaya inap posisi Long -0.0249%
    Biaya inap posisi short 0.0027%
    Waktu biaya inap 21:00 (UTC)
    Spread 3.0

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    Biaya inap posisi Long -0.0185%
    Biaya inap posisi short 0.0102%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda